Archiving Policy

The Journal of Cancer and Translational Oncology (JCTO) is committed to the long-term preservation, accessibility, and reliability of all published scholarly content in oncology and translational medicine.

All published articles are permanently archived in digital format and remain freely accessible online. The journal ensures that all content is securely stored and maintained to prevent data loss and to guarantee continuous access for the global scientific and medical community.

Digital Preservation

To ensure long-term preservation, the journal follows established digital archiving practices, including secure servers, regular backups, and systematic content management. These measures safeguard the integrity and availability of published research over time.

DOI Assignment and Accessibility

Each published article is assigned a Digital Object Identifier (DOI), ensuring permanent identification, stable citation, and long-term discoverability. Articles are made available in downloadable PDF format for ease of access and global distribution.

Indexing and Repository Support

The journal supports indexing in major scholarly databases and encourages authors to deposit their published work in institutional repositories and academic platforms. This enhances visibility, accessibility, and research impact.

Author Self-Archiving

Authors are permitted to archive their published articles in institutional repositories, personal websites, or academic networking platforms, provided that proper citation to the original publication in the Journal of Cancer and Translational Oncology is maintained.

Platform Continuity

In the event of system upgrades, migration, or technical changes, all archived content will be securely transferred to ensure uninterrupted access and continuity of the scholarly record.

Commitment

Through this archiving policy, the Journal of Cancer and Translational Oncology reaffirms its commitment to open access principles, long-term preservation, and the global dissemination of high-quality cancer research.